The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Double-loaded mature dendritic cell (DC) therapy for non-HLA-restricted patients with advanced ovarian cancer: Final results of a clinical phase I study.
Marianne Imhof
No relevant relationships to disclose
Markus Lipovac
No relevant relationships to disclose
Lukas Angleitner-Boubenizek
No relevant relationships to disclose
Johannes Barta
No relevant relationships to disclose
Ivan Gomez
No relevant relationships to disclose
Astrid Hrdina
No relevant relationships to disclose
Ewa Krupa
No relevant relationships to disclose
Judith Lafleur
No relevant relationships to disclose
Istvan Lang
No relevant relationships to disclose
Katharin Pieta
No relevant relationships to disclose
Heike Rottmann
No relevant relationships to disclose
Martin Imhof
No relevant relationships to disclose